These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 35121343)

  • 41. Metabolism of oxidized phosphatidylcholines formed in oxidized low density lipoprotein by lecithin-cholesterol acyltransferase.
    Itabe H; Hosoya R; Karasawa K; Jimi S; Saku K; Takebayashi S; Imanaka T; Takano T
    J Biochem; 1999 Jul; 126(1):153-61. PubMed ID: 10393333
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular basis for activation of lecithin:cholesterol acyltransferase by a compound that increases HDL cholesterol.
    Manthei KA; Yang SM; Baljinnyam B; Chang L; Glukhova A; Yuan W; Freeman LA; Maloney DJ; Schwendeman A; Remaley AT; Jadhav A; Tesmer JJ
    Elife; 2018 Nov; 7():. PubMed ID: 30479275
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evidence for deficiency of high density lipoprotein lecithin: cholesterol acyltransferase activity (alpha-LCAT) in fish eye disease.
    Carlson LA; Holmquist L
    Acta Med Scand; 1985; 218(2):189-96. PubMed ID: 4061122
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dietary fatty acid modification of HDL phospholipid molecular species alters lecithin: cholesterol acyltransferase reactivity in cynomolgus monkeys.
    Thornburg JT; Parks JS; Rudel LL
    J Lipid Res; 1995 Feb; 36(2):277-89. PubMed ID: 7751815
    [TBL] [Abstract][Full Text] [Related]  

  • 45. T13M mutation of lecithin-cholesterol acyltransferase gene causes fish-eye disease.
    Miida T; Zhang B; Obayashi K; Seino U; Zhu Y; Ito T; Nakamura Y; Okada M; Saku K
    Clin Chim Acta; 2004 May; 343(1-2):201-8. PubMed ID: 15115696
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The P274S Mutation of Lecithin-Cholesterol Acyltransferase (LCAT) and Its Clinical Manifestations in a Large Kindred.
    Fountoulakis N; Lioudaki E; Lygerou D; Dermitzaki EK; Papakitsou I; Kounali V; Holleboom AG; Stratigis S; Belogianni C; Syngelaki P; Stratakis S; Evangeliou A; Gakiopoulou H; Kuivenhoven JA; Wevers R; Dafnis E; Stylianou K
    Am J Kidney Dis; 2019 Oct; 74(4):510-522. PubMed ID: 31103331
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lecithin:cholesterol acyltransferase: symposium on 50 years of biomedical research from its discovery to latest findings.
    Norum KR; Remaley AT; Miettinen HE; Strøm EH; Balbo BEP; Sampaio CATL; Wiig I; Kuivenhoven JA; Calabresi L; Tesmer JJ; Zhou M; Ng DS; Skeie B; Karathanasis SK; Manthei KA; Retterstøl K
    J Lipid Res; 2020 Aug; 61(8):1142-1149. PubMed ID: 32482717
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of human lecithin:cholesterol acyltransferase in transgenic mice: effects on cholesterol efflux, esterification, and transport.
    Francone OL; Haghpassand M; Bennett JA; Royer L; McNeish J
    J Lipid Res; 1997 Apr; 38(4):813-22. PubMed ID: 9144096
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Safety and Tolerability of ACP-501, a Recombinant Human Lecithin:Cholesterol Acyltransferase, in a Phase 1 Single-Dose Escalation Study.
    Shamburek RD; Bakker-Arkema R; Shamburek AM; Freeman LA; Amar MJ; Auerbach B; Krause BR; Homan R; Adelman SJ; Collins HL; Sampson M; Wolska A; Remaley AT
    Circ Res; 2016 Jan; 118(1):73-82. PubMed ID: 26628614
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lecithin: cholesterol acyltransferase expression has minimal effects on macrophage reverse cholesterol transport in vivo.
    Tanigawa H; Billheimer JT; Tohyama J; Fuki IV; Ng DS; Rothblat GH; Rader DJ
    Circulation; 2009 Jul; 120(2):160-9. PubMed ID: 19564558
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Surface plasmon resonance biosensor studies of human wild-type and mutant lecithin cholesterol acyltransferase interactions with lipoproteins.
    Jin L; Shieh JJ; Grabbe E; Adimoolam S; Durbin D; Jonas A
    Biochemistry; 1999 Nov; 38(47):15659-65. PubMed ID: 10569952
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lecithin:cholesterol acyltransferase-mediated modification of discoidal peripheral lymph high density lipoproteins: possible mechanism of formation of cholesterol-induced high density lipoproteins (HDLc) in cholesterol-fed dogs.
    Dory L; Sloop CH; Boquet LM; Hamilton RL; Roheim PS
    Proc Natl Acad Sci U S A; 1983 Jun; 80(11):3489-93. PubMed ID: 6574494
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ApoE and apoC-III-defined HDL subtypes: a descriptive study of their lecithin cholesterol acyl transferase and cholesteryl ester transfer protein content and activity.
    Amaya-Montoya M; Pinzón-Cortés JA; Silva-Bermúdez LS; Ruiz-Manco D; Pérez-Matos MC; Jiménez-Mora MA; Mendivil CO
    Lipids Health Dis; 2020 May; 19(1):106. PubMed ID: 32450892
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro expression of natural mutants of human lecithin:cholesterol acyltransferase.
    Qu SJ; Fan HZ; Blanco-Vaca F; Pownall HJ
    J Lipid Res; 1995 May; 36(5):967-74. PubMed ID: 7658168
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Overexpression of human lecithin cholesterol acyltransferase leads to hyperalphalipoproteinemia in transgenic mice.
    Vaisman BL; Klein HG; Rouis M; Bérard AM; Kindt MR; Talley GD; Meyn SM; Hoyt RF; Marcovina SM; Albers JJ
    J Biol Chem; 1995 May; 270(20):12269-75. PubMed ID: 7744879
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Functional lecithin: cholesterol acyltransferase is not required for efficient atheroprotection in humans.
    Calabresi L; Baldassarre D; Castelnuovo S; Conca P; Bocchi L; Candini C; Frigerio B; Amato M; Sirtori CR; Alessandrini P; Arca M; Boscutti G; Cattin L; Gesualdo L; Sampietro T; Vaudo G; Veglia F; Calandra S; Franceschini G
    Circulation; 2009 Aug; 120(7):628-35. PubMed ID: 19687369
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The HDL mimetic CER-001 remodels plasma lipoproteins and reduces kidney lipid deposits in inherited lecithin:cholesterol acyltransferase deficiency.
    Pavanello C; Turri M; Strazzella A; Tulissi P; Pizzolitto S; De Maglio G; Nappi R; Calabresi L; Boscutti G
    J Intern Med; 2022 Mar; 291(3):364-370. PubMed ID: 34761839
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Low plasma lecithin:cholesterol acyltransferase and lipid transfer protein activities in growth hormone deficient and acromegalic men: role in altered high density lipoproteins.
    Beentjes JA; van Tol A; Sluiter WJ; Dullaart RP
    Atherosclerosis; 2000 Dec; 153(2):491-8. PubMed ID: 11164439
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Atherogenic impact of lecithin-cholesterol acyltransferase and its relation to cholesterol esterification rate in HDL (FER(HDL)) and AIP [log(TG/HDL-C)] biomarkers: the butterfly effect?
    Dobiášová M
    Physiol Res; 2017 May; 66(2):193-203. PubMed ID: 28471688
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [LCAT (lecithin:cholesterol acyltransferase)].
    Kinoshita M; Teramoto T
    Rinsho Byori; 2001 Nov; Suppl 116():125-30. PubMed ID: 11797372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.